title: Vasculitis syndromes: which maintenance therapy for ANCA vasculitis?
abstract: Antineutrophil cytoplasmic antibody-associated vasculitides are usually treated with a combination of high-dose corticosteroids and cyclophosphamide therapy to induce remission, commonly followed by maintenance treatment with a less-toxic immunosuppressant. Azathioprine and methotrexate are both options for maintenance therapy, but whether one of these immunosuppressants is superior to the other is unclear.
authors.affiliation: UNC Kidney Center, University of North Carolina, Chapel Hill, NC 27599, USA. patrick_nachman@med.unc.edu
authors.forename: Patrick H
authors.initials: PH
authors.lastname: Nachman
mesh_terms: D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D014657:Vasculitis / Q000188:drug therapy* / Q000276:immunology*
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D007166:Immunosuppressive Agents